CSF1R and Alzheimer disease: Here, we partially depleted microglia within the AD brain with PLX5622, a CSF1R inhibitor, and then allowed microglia to repopulate in order to investigate whether renewing microglia through this method could affect cognitive deficits, plaque formation, and Tau hyperphosphorylation in two mouse models of AD.